Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





Beckman Coulter Spotlights Latest Advancements in Laboratory Diagnostics at AACC 2022

By LabMedica International staff writers
Posted on 26 Jul 2022
Print article
Image: The new DxA 5000 Fit Workflow Automation System was demonstrated at AACC 2022 (Photo courtesy of Beckman Coulter)
Image: The new DxA 5000 Fit Workflow Automation System was demonstrated at AACC 2022 (Photo courtesy of Beckman Coulter)

Beckman Coulter, Inc. (Brea, CA, USA) will highlight its latest medical advancements in laboratory solutions at the 2022 AACC Clinical Lab Expo that streamline workflows, enhance productivity and bring automation to labs of all sizes. The company will also give live presentation on sepsis diagnosis and management highlighting the use of standardized laboratory and clinical operations in the context of a patient’s journey from initial assessment in the Emergency Department through treatment in the Intensive Care Unit (ICU) to eventual discharge.

At AACC 2022, Beckman Coulter is providing a booth tour to allow visitors to experience the total solution in the laboratory and an innovation tour to experience the future in healthcare. The company will be demonstrating the new DxA 5000 Fit Workflow Automation System, an automation solution that fundamentally improves lab workflow by making intelligent automation accessible to fit small- and mid-sized lab needs. The DxA 5000 Fit drives speed and accuracy, all while maintaining a small footprint. It eliminates up to 80% of the manual steps associated with processing a patient sample, allowing users to focus on patient care.

Among its portfolio of clinical informatics solutions, Beckman Coulter is demonstrating the DxONE Information Management Solutions. This includes the DxONE Inventory Manager, an automated, end-to-end software application that increases operational efficiency by automatically recording, tracking and optimizing a laboratory’s consumables; the new DxONE Workflow Manager which is the industry’s first cloud-based middleware solution that allows users to amplify productivity and future-proof their lab; the DxONE Command Central that allows labs to establish a centralized point of control connecting up to 18 instruments or automation systems across the network; and the DxONE Insights, a cloud-based software solution that provides actionable insights and lab data analytics to streamline operations, allowing labs to identify patterns and reduce inefficiencies.

Beckman Coulter is also demonstrating its range of scalable clinical chemistry analyzers that can help optimize a lab’s uptime, reliability and performance, including the AU480 chemistry analyzer which is the ideal primary clinical chemistry analyzer for low- to mid-volume hospitals and laboratories, or dedicated specialty chemistry or STAT analyzer for larger laboratories; the DxC 700 AU clinical chemistry analyzer for mid- to high-volume laboratories that combines the features of the DxC and AU series of clinical chemistry analyzers; and the AU5800 series clinical chemistry analyzers that are the fastest in the industry, processing up to 2,000 tests per hour with a full menu of assays.

Among its hematology solutions, Beckman Coulter is presenting the DxH 900 hematology analyzer that enables high-volume laboratories to achieve superb RBC, PLT and WBC differentials through near native-state cellular characterization; the DxH 690T 5-part differential CBC analyzer that delivers rapid patient results, while enabling technologists to simplify processes and reduce manual tasks; and the new DxH 560 AL hematology analyzer that helps save time and resources, eliminate manual intervention and deliver high-quality results, even for difficult-draw patient groups.
 

Related Links:
Beckman Coulter, Inc. 

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Typhoid Rapid Test
OnSite Typhoid IgG/IgM Combo Rapid Test
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.